12:00 AM
 | 
Sep 02, 2013
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Inovio preclinical data

In mice and non-human primates, Inovio's SynCon malaria DNA vaccine produced "robust and sustained" antibody responses to all 4 malaria antigens tested, according to the company. The vaccine also...

Read the full 124 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >